Poor linear growth (i.e. stunting), is common in perinatally-acquired HIV infection, yet effects of HIV on adolescent musculoskeletal development remain poorly characterized in sub-Saharan Africa. We hypothesize that bone and muscle growth in children living with HIV (CWH) are impaired, putting them at risk of low bone mass and functional disability, which may increase future fracture risk. We aimed to determine the impact of HIV on size-adjusted (important in context of small stature) bone density and muscle function in peri-pubertal children in Zimbabwe.
CWH aged 8-16 years, established on ART for ≥2 years, from two public sector HIV clinics and sex and aged-band frequency-matched uninfected children from schools were recruited. Musculoskeletal assessments included grip strength, standing long jump and dual-energy X-ray absorptiometry (DXA). Total-body less-head (TBLH) bone mineral content (BMC) for lean mass adjusted for height (TBLH BMCLBM) and lumbar spine bone mineral apparent density (LS BMAD) values and Z-Scores were calculated. Differences by HIV status, and risk factors for impaired musculoskeletal measures, were determined using linear and logistic regression.
A total of 284 CWH and 222 children without HIV were recruited (Table 1). CWH were more likely to have pubertal delay, stunting and wasting than children without HIV. Calcium and vitamin D intake were not significantly different between the two groups. However, CWH had significantly lower muscle mass, muscle strength, TBLH BMCLBM and LS BMAD compared to the uninfected controls.
This study, for the first time, investigated the effect of HIV on bone and muscle development sub-Saharan African children. HIV was found to have a profound effect on muscle function and bone mass. Whilst pubertal delay is more common in HIV, it does not account for these differences. The effect of HIV on musculoskeletal health may result in long-term disability and impaired quality of life in the future.